Sessions
Building a Common Digital Approach to Unleash the Sector: An Industry Consensus
Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L
How to Deliver a Fully Funded, 3rd Party Biotech Facility 3 Years Faster Than Traditional Build Construction Method
Cell Sorter for Next CT Products : Sangamo & Sony Biotechnology Journey
Ancillary Material Considerations for a Seamless Transition into GMP Manufacturing
Overcoming the Challenges of Outsourcing Cell & Gene Therapy Trials
Leveraging Partnerships to Achieve Clinical & Commercial Success
De-Risk. Deploy. Deliver. Key Considerations to Pick the Right CDMO During your Cell Therapy Development Process
Building a Common Digital Approach to Unleash the Sector: An Industry Consensus
SPONSORED BY
This is a unique opportunity to be integral in defining solutions to digital infrastructure, data and systems challenges, through a pre-competitive and collaborative environment with guided activities and discussions in order to:
• Drive consensus, alignment and collaboration in the CGT community around critical needs – and provide you with a landscape of the challenges and how they can be addressed
• Understand the diverse needs and opportunities, from across the CGT value chain, with leaders participating from academia, industry, regulatory agencies, facility developers, equipment manufacturers, providers in the automation, healthcare and digital industries
Agenda
5:00pm Panel
5:40pm Q&A
Speakers:
Paolo Siciliano, Cell & Gene Expert, PA Consulting
Stephen Ward, Chief Manufacturing Officer, Cell & Gene Therapy Catapult
Andrew Earnshaw, Digital Health Expert, PA Consulting
Phil Vanek, Chief Technology Officer, Gamma Biosciences
Fabio Fachin, Head of Cell Therapy Process Development, Takeda
Speakers
